Loading clinical trials...
Loading clinical trials...
Predicting Recurrence-Free Survival in Stage III and High-Risk Stage II Colorectal Cancer After Curative-Intent Treatment
Conditions
Interventions
CENSURE
Locations
4
United States
City of Hope Medical Center
Monrovia, California, United States
Second Affiliated Hospital of Dalian Medical University
Dalian, China
Barcelona University
Barcelona, Spain
La Paz University Hospital
Madrid, Spain
Start Date
March 15, 2023
Primary Completion Date
June 18, 2026
Completion Date
June 18, 2026
Last Updated
July 4, 2025
NCT02600949
NCT07446322
NCT05919264
NCT07541924
NCT07536113
NCT07537491
Lead Sponsor
City of Hope Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions